Drug Patents owned by Athena

1. Drug name - FIBRICOR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7569612 ATHENA Methods of use of fenofibric acid Aug, 2027

(4 years from now)

US7741373 ATHENA Methods of use of fenofibric acid Aug, 2027

(4 years from now)

US7915247 ATHENA Methods of use of fenofibric acid Aug, 2027

(4 years from now)

US7741374 ATHENA Methods of use of fenofibric acid Aug, 2027

(4 years from now)

Drugs and Companies using FENOFIBRIC ACID ingredient

Treatment: Adjunctive therapy to diet in patients with hyperlipidemias; Adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctive therapy to diet in patients with hyperlipidemias; adjunctive therapy to diet in patients with mixed dyslipidemia; adjunctive therapy to diet to patients with hypertriglyceridemia; Adjunctive therapy to diet in patients with mixed dyslipidemia; adjunctive therapy to diet in patients with elevated cholesterol and/or lipid levels

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
35MG TABLET;ORAL Discontinued
105MG TABLET;ORAL Prescription

2. Drug name - NEXICLON XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8337890 ATHENA Modified release formulations containing drug-ion exchange resin complexes Apr, 2027

(4 years from now)

US8623409 ATHENA Clonidine formulation Sep, 2031

(8 years from now)

Drugs and Companies using CLONIDINE ingredient

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 0.17MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 0.26MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued

3. Drug name - QDOLO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103452 ATHENA Tramadol hydrochloride solution Sep, 2040

(17 years from now)

Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient

Treatment: Management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
5MG/ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.